CAPTRUST Financial Advisors’s Sana Biotechnology SANA Stock Holding History

CAPTRUST Financial Advisors’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$54.8K	Sell	15,713 -130	-0.8%	-$419	﹤0.01%	3123
2026 Q1	$45.6K	Sell	15,843 -601	-4%	-$2.37K	﹤0.01%	2908
2025 Q4	$66.9K	Buy	16,444 +1,227	+8%	+$5.5K	﹤0.01%	2654
2025 Q3	$54K	Sell	15,217 -576	-4%	-$2.08K	﹤0.01%	2555
2025 Q2	$43.1K	Buy	15,793 +4,807	+44%	+$9.92K	﹤0.01%	2440
2025 Q1	$18.5K	Buy	+10,986	New	+$30.7K	﹤0.01%	2323
2022 Q2	–	Sell	-36	Closed	–	–	5110
2022 Q1	$0	Sell	36 -2	-5%	-$16	﹤0.01%	5105
2021 Q4	$1K	Buy	+38	New	+$733	﹤0.01%	4624

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

CAPTRUST Financial Advisors's SANA Position: Q2 2026 in Review

CAPTRUST Financial Advisors reduced its Sana Biotechnology (SANA) stake by 0.82% in Q2 2026, selling an estimated $419 and leaving 15,713 shares worth $54.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3123.

CAPTRUST Financial Advisors first reported a position in SANA in Q4 2021 and has held it in 8 quarters since. The position peaked at $66.9K in Q4 2025. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

CAPTRUST Financial Advisors held 15,713 shares of Sana Biotechnology worth $54.8K as of Q2 2026.
CAPTRUST Financial Advisors sold 130 Sana Biotechnology shares in Q2 2026, an estimated $419.
Sana Biotechnology made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #3123 holding.
CAPTRUST Financial Advisors first reported a position in Sana Biotechnology in Q4 2021 and has held it in 8 quarters since.
CAPTRUST Financial Advisors's Sana Biotechnology position peaked at $66.9K in Q4 2025.
211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.